亨迪药业
(301211)
| 流通市值：39.05亿 | | | 总市值：39.05亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 425,282,964.5 | 447,658,499.51 | 544,621,483.35 | 540,169,434.72 |
| 交易性金融资产 | 1,114,682,763.47 | 1,107,277,763.47 | 1,025,766,875.01 | 1,029,842,597.25 |
| 应收票据及应收账款 | 84,828,815.53 | 78,618,968.68 | 49,233,445.95 | 72,338,203.25 |
| 其中：应收票据 | 12,750,342.42 | 15,146,626.5 | 6,884,003.7 | 4,124,611.71 |
| 应收账款 | 72,078,473.11 | 63,472,342.18 | 42,349,442.25 | 68,213,591.54 |
| 应收款项融资 | 14,711,254.6 | 12,850,668.66 | 7,397,670.45 | 1,380,302.79 |
| 预付款项 | 6,398,573.81 | 4,562,437.01 | 5,993,392.74 | 2,218,392.25 |
| 其他应收款合计 | 4,877,105.74 | 4,151,904.4 | 5,469,539.81 | 4,902,373.61 |
| 存货 | 125,837,058.47 | 122,677,371.65 | 122,021,282.74 | 115,895,947.25 |
| 其他流动资产 | 15,589,640.03 | 13,806,017.15 | 20,616,821.63 | 14,176,361.5 |
| 流动资产合计 | 1,792,208,176.15 | 1,791,603,630.53 | 1,781,120,511.68 | 1,780,923,612.62 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,382,661.59 | 10,382,661.59 | 9,584,716.09 | 9,584,716.09 |
| 固定资产 | 512,241,522.02 | 515,746,923.96 | 462,763,684.54 | 462,632,558.28 |
| 在建工程 | 10,435,160.84 | 8,202,085.85 | 73,396,769.51 | 63,185,085.96 |
| 使用权资产 | 1,700,592.09 | 1,943,533.8 | 2,186,475.51 | 2,429,417.22 |
| 无形资产 | 66,297,188.35 | 66,825,447.76 | 67,353,707.17 | 67,881,966.58 |
| 开发支出 | 3,628,776.93 | 3,613,600 | 1,683,600 | 623,600 |
| 长期待摊费用 | 681,695.59 | 761,848.87 | 833,272.21 | 904,695.55 |
| 递延所得税资产 | 2,363,541.08 | 2,363,541.08 | 2,195,160.87 | 2,195,160.87 |
| 其他非流动资产 | 179,994.9 | 433,994.9 | 376,156.45 | 1,813,319.56 |
| 非流动资产合计 | 607,911,133.39 | 610,273,637.81 | 620,373,542.35 | 611,250,520.11 |
| 资产总计 | 2,400,119,309.54 | 2,401,877,268.34 | 2,401,494,054.03 | 2,392,174,132.73 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 59,403,054.7 | 72,271,797.48 | 92,143,840.85 | 85,318,671.02 |
| 应付账款 | 59,403,054.7 | 72,271,797.48 | 92,143,840.85 | 85,318,671.02 |
| 合同负债 | 15,954,009.07 | 9,149,894.59 | 12,879,771.1 | 9,612,748.92 |
| 应付职工薪酬 | 10,392,301.61 | 13,433,333.02 | 11,968,711.55 | 10,995,667.7 |
| 应交税费 | 4,327,658.44 | 4,664,682.93 | 1,729,921.06 | 2,506,620.8 |
| 其他应付款合计 | 2,858,215.72 | 1,952,935.28 | 3,934,727.69 | 6,209,725.67 |
| 一年内到期的非流动负债 | 1,126,554.93 | 1,126,554.93 | 1,094,588.44 | 1,094,588.44 |
| 其他流动负债 | 10,263,788.8 | 11,950,642.32 | 3,908,775.57 | 4,642,262.78 |
| 流动负债合计 | 104,325,583.27 | 114,549,840.55 | 127,660,336.26 | 120,380,285.33 |
| 非流动负债: | | | | |
| 租赁负债 | 1,222,386.94 | 2,007,821.9 | 2,005,538.77 | 2,375,242.37 |
| 递延收益 | 1,954,645.62 | 1,963,758.84 | 2,012,393.14 | 2,021,506.36 |
| 递延所得税负债 | 10,127,764.71 | 10,127,764.71 | 10,508,064.7 | 10,508,064.7 |
| 非流动负债合计 | 13,304,797.27 | 14,099,345.45 | 14,525,996.61 | 14,904,813.43 |
| 负债合计 | 117,630,380.54 | 128,649,186 | 142,186,332.87 | 135,285,098.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 417,600,000 | 417,600,000 | 417,600,000 | 288,000,000 |
| 资本公积 | 1,626,912,267.22 | 1,626,912,267.22 | 1,626,912,267.22 | 1,756,512,267.22 |
| 其他综合收益 | 325,262.35 | 325,262.35 | -352,991.32 | -352,991.32 |
| 专项储备 | 42,783.01 | - | 735,136.09 | 702,721.51 |
| 盈余公积 | 61,020,576.93 | 61,020,576.93 | 57,925,227.06 | 57,925,227.06 |
| 未分配利润 | 176,588,039.49 | 167,369,975.84 | 156,488,082.11 | 154,101,809.5 |
| 归属于母公司股东权益合计 | 2,282,488,929 | 2,273,228,082.34 | 2,259,307,721.16 | 2,256,889,033.97 |
| 股东权益合计 | 2,282,488,929 | 2,273,228,082.34 | 2,259,307,721.16 | 2,256,889,033.97 |
| 负债和股东权益合计 | 2,400,119,309.54 | 2,401,877,268.34 | 2,401,494,054.03 | 2,392,174,132.73 |
| 公告日期 | 2026-04-23 | 2026-03-31 | 2025-10-28 | 2025-08-01 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |